20 Aug, 2024 The potential turnaround of advertising and promotion rules for medicines in Brazil By Bruna Rocha Juliana Marcondes Victoria Cristofaro New STJ decision may redefine rules in the health sector, including RDC 96/2008 On August 14, 2024, Justice Regina Helena Costa of the...
14 Aug, 2024 Drug discovery and development in the age of AI By Rebecca Lawrence DLA Piper’s inaugural Life Sciences Index is a survey and study series about perceptions of innovation and growth in the life sciences...
14 Aug, 2024 Wearables and the rise of standard essential patents in the life sciences sector By Petros Nafpliotis Tabitha Norris The integration of advanced technologies in the life sciences sector is leading to a transformative shift in the industry as innovations...
14 Aug, 2024 An AnoxyGen-eration of new drugs? Natural products and their patentability By Tabitha Norris Georgina Doukanaris Natural products (i.e. products produced by living organisms such as plants, animals and microbes) have historically been a major...
14 Aug, 2024 Mushrooms are not plant varieties under Art. 53(b) EPC By Hannah Gardiner A nod to the 'muggle' mushroom - A recent patent dispute concerning the common mushroom may be relevant for those operating in the field...
08 Aug, 2024 Life Sciences News in Italy: July 2024 By DLA Piper Life Sciences Regulatory AI Act enters into force On 12 July 2024, Regulation (EU) 2024/1689 (AI Act) was published in the EU Official Journal. The AI...
05 Aug, 2024 Poland - Life Sciences Monthly Brief, July 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...